TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biotech-IgG Equity AB (publ)
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 12,282 | 5,536 | 19,657 |
Financial expenses | 4,113 | 539 | 912 |
Earnings before taxes | -85,838 | 2,246 | -4,512 |
EBITDA | 956 | -681 | -3,554 |
Total assets | 89,556 | 174,330 | 9,088 |
Current assets | 28,276 | 16,582 | 8,411 |
Current liabilities | 30,723 | 45,447 | 2,753 |
Equity capital | 55,127 | 128,883 | 5,185 |
- share capital | 76,196 | 69,628 | 8,391 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 61.6% | 73.9% | 57.1% |
Turnover per employee | 6,141 | 2,768 | 9,828 |
Profit as a percentage of turnover | -698.9% | 40.6% | -23.0% |
Return on assets (ROA) | -91.3% | 1.6% | -39.6% |
Current ratio | 92.0% | 36.5% | 305.5% |
Return on equity (ROE) | -155.7% | 1.7% | -87.0% |
Change turnover | 6,746 | -14,121 | -19,692 |
Change turnover % | 122% | -72% | -50% |
Chg. No. of employees | 0 | 0 | -1 |
Chg. No. of employees % | 0% | 0% | -33% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.